Compagnie Lombard Odier SCmA’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,562
Closed -$378K 540
2020
Q1
$314K Hold
9,562
0.01% 209
2019
Q4
$352K Hold
9,562
0.01% 213
2019
Q3
$321K Hold
9,562
0.01% 209
2019
Q2
$376K Hold
9,562
0.02% 198
2019
Q1
$388K Hold
9,562
0.02% 219
2018
Q4
$310K Buy
+9,562
New +$386K 0.01% 230
2018
Q2
Sell
-250
Closed -$13K 618
2018
Q1
$13K Sell
250
-250
-50% -$13.3K ﹤0.01% 539
2017
Q4
$26K Buy
500
+250
+100% +$12.4K ﹤0.01% 570
2017
Q3
$12K Hold
250
﹤0.01% 632
2017
Q2
$12K Hold
250
﹤0.01% 643
2017
Q1
$11K Sell
250
-6,800
-96% -$281K ﹤0.01% 668
2016
Q4
$298K Buy
7,050
+100
+1% +$4.08K 0.01% 393
2016
Q3
$305K Hold
6,950
0.01% 410
2016
Q2
$303K Buy
6,950
+150
+2% +$6.46K 0.01% 422
2016
Q1
$299K Hold
6,800
0.01% 420
2015
Q4
$286K Hold
6,800
0.01% 415
2015
Q3
$267K Sell
6,800
-120
-2% -$4.89K 0.01% 364
2015
Q2
$288K Buy
6,920
+1,620
+31% +$69.2K 0.01% 384
2015
Q1
$220K Sell
5,300
-400
-7% -$15.4K 0.01% 466
2014
Q4
$212K Buy
+5,700
New +$205K 0.01% 407

Other funds holding FMS

Compagnie Lombard Odier SCmA's FMS Position: Q2 2020 in Review

Compagnie Lombard Odier SCmA sold out of Fresenius Medical Care (FMS) in Q2 2020, closing a stake of 9,562 shares — an estimated $378K sold.

Compagnie Lombard Odier SCmA first reported a position in FMS in Q4 2014 and held it in 20 quarters. The position peaked at $388K in Q1 2019. 179 funds tracked by Wall St. Rank hold FMS as of Q2 2020.

  • Compagnie Lombard Odier SCmA reported no remaining Fresenius Medical Care position as of Q2 2020 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 9,562 Fresenius Medical Care shares in Q2 2020, an estimated $378K.
  • Compagnie Lombard Odier SCmA first reported a position in Fresenius Medical Care in Q4 2014 and held it in 20 quarters.
  • Compagnie Lombard Odier SCmA's Fresenius Medical Care position peaked at $388K in Q1 2019.
  • 179 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2020, filed 14 Aug 2020.